Literature DB >> 20458689

Osteoclastic bioresorption of biomaterials: two- and three-dimensional imaging and quantification.

Thomas Winkler1, Elisa Hoenig, Gerd Huber, Rolf Janssen, Daniel Fritsch, Renate Gildenhaar, Georg Berger, Michael M Morlock, Arndt F Schilling.   

Abstract

PURPOSE: Bioresorbable materials have been developed in the hope that the body will replace them with newly formed tissue. The first step of this remodeling process in bone is the bioresorption of the material by osteoclasts. The aim of this study was to analyze osteoclastic resorption of biomaterials in vitro using the commonly used two-dimensional methods of light-microscopy (LM) and scanning electron microscopy (SEM) in comparison with infinite focus microscopy (IFM), a recently developed imaging method allowing for three-dimensional surface analysis.
METHODS: Human hematopoietic stem cells were cultivated in the presence of the cytokines M-CSF and RANK-L for 4 weeks directly on dentin and a calcium phosphate cement. Osteoclast development was surveyed with standard techniques. After removal of the cells, resorption was characterized and quantified by LM, SEM and IFM.
RESULTS: Osteoclast cultures on the biomaterials presented the typical osteoclast-specific markers. On dentin samples LM, SEM as well as IFM allowed for discrimination of resorption. Quantification of the resorbed area showed a linear correlation between the results (LM vs. SEM: r=0.996, p=0.004; SEM vs. IFM: r=0.989, p=0.011; IFM vs. LM: r=0.995). It was not possible to demarcate resorption pits on GB14 using LM or SEM. With IFM, resorption on GB14 could be visualized and quantified two- and three-dimensionally.
CONCLUSIONS: In this paper we introduce IFM as a technology for three-dimensional visualization and quantification of resorption of biomaterials. Better understanding of the bioresorption of biomaterials may help in the design of better materials and might therefore constitute an important step on the avenue to the development of artificial bone.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20458689

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  6 in total

1.  Assay of in vitro osteoclast activity on dentine, and synthetic calcium phosphate bone substitutes.

Authors:  Zahi Badran; Paul Pilet; Elise Verron; Jean-Michel Bouler; Pierre Weiss; Gaël Grimandi; Jérôme Guicheux; Assem Soueidan
Journal:  J Mater Sci Mater Med       Date:  2011-12-22       Impact factor: 3.896

2.  Biodegradable poly (lactic acid-co-glycolic acid) scaffolds as carriers for genetically-modified fibroblasts.

Authors:  Tatjana Perisic; Ziyang Zhang; Peter Foehr; Ursula Hopfner; Kathrin Klutz; Rainer H Burgkart; Alexei Slobodianski; Moritz Goeldner; Hans-Günther Machens; Arndt F Schilling
Journal:  PLoS One       Date:  2017-04-05       Impact factor: 3.240

Review 3.  Current State of Bone Adhesives-Necessities and Hurdles.

Authors:  Kai O Böker; Katharina Richter; Katharina Jäckle; Shahed Taheri; Ingo Grunwald; Kai Borcherding; Janek von Byern; Andreas Hartwig; Britt Wildemann; Arndt F Schilling; Wolfgang Lehmann
Journal:  Materials (Basel)       Date:  2019-11-30       Impact factor: 3.623

4.  Real-time quantification of osteoclastic resorptive activity by electric cell-substrate impedance sensing.

Authors:  Ineke D C Jansen; Thijs van Velzen; Teun J de Vries; Robert Szulcek; Jack J W A van Loon
Journal:  Front Cell Dev Biol       Date:  2022-08-19

5.  Divergent resorbability and effects on osteoclast formation of commonly used bone substitutes in a human in vitro-assay.

Authors:  Johannes Keller; Silja Brink; Björn Busse; Arndt F Schilling; Thorsten Schinke; Michael Amling; Tobias Lange
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

6.  Osteoidosis leads to altered differentiation and function of osteoclasts.

Authors:  Lisanne Grünherz; Carina Prein; Thomas Winkler; Manuela Kirsch; Ursula Hopfner; Thomas Streichert; Hauke Clausen-Schaumann; Jozef Zustin; Kristin Kirchhof; Michael M Morlock; Hans-Günter Machens; Arndt Friedrich Schilling
Journal:  J Cell Mol Med       Date:  2020-04-13       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.